Serge Saxonov - Mar 17, 2025 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Chief Executive Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Serge Saxonov
Stock symbol
TXG
Transactions as of
Mar 17, 2025
Transactions value $
$0
Form type
4
Date filed
3/19/2025, 05:35 PM
Previous filing
Mar 4, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Award $0 +171K +18.6% $0.00 1.09M Mar 17, 2025 Direct F1
holding TXG Class A Common Stock 27 Mar 17, 2025 See footnote F2
holding TXG Class A Common Stock 870 Mar 17, 2025 See footnote F3
holding TXG Class A Common Stock 213K Mar 17, 2025 See footnote F4
holding TXG Class A Common Stock 22.6K Mar 17, 2025 See footnote F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/12th of the RSUs shall vest on each quarterly anniversary measured from February 21, 2025, subject to the Reporting Person continuing as a service provider through each such date.
F2 The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
F3 The shares are held by the Sirius Trust, for which the Reporting Person serves as trustee.
F4 The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
F5 The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.